Febuxostat: a review of its use in the treatment of hyperuricaemia in patients with gout.
about
Pharmacokinetics and Bioequivalence of Two Formulations of Febuxostat 40-Mg and 80-Mg Tablets: A Randomized, Open-Label, 4-Way Crossover Study in Healthy Chinese Male VolunteersFebuxostat-induced agranulocytosis in an end-stage renal disease patient: A case report.Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease.Treatment Options for Gout.Allopurinol induces innate immune responses through mitogen-activated protein kinase signaling pathways in HL-60 cells.Risk of Febuxostat-Associated Myopathy in Patients with CKD.Effects of febuxostat on insulin resistance and expression of high-sensitivity C-reactive protein in patients with primary gout.
P2860
Q35956067-CA334ED8-9744-48EE-B4D1-32E46C5FE356Q37606382-ECE85A4B-1898-4F10-860D-78EAECEECB20Q38595252-DD2E3E7B-43AF-4FC3-8014-4F153622D5B7Q38691902-9011D5A6-DEC6-4564-A1AC-D3C75F2028AAQ38814020-1F75A591-5D5B-4FA0-9783-D1E6E681FBFEQ40288477-8B4A40A9-4885-45FC-B750-EE89C73265F1Q51275986-3304D3E7-39AB-44BD-8054-10E9ECE26506
P2860
Febuxostat: a review of its use in the treatment of hyperuricaemia in patients with gout.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Febuxostat: a review of its use in the treatment of hyperuricaemia in patients with gout.
@en
type
label
Febuxostat: a review of its use in the treatment of hyperuricaemia in patients with gout.
@en
prefLabel
Febuxostat: a review of its use in the treatment of hyperuricaemia in patients with gout.
@en
P2860
P1433
P1476
Febuxostat: a review of its use in the treatment of hyperuricaemia in patients with gout.
@en
P2093
James E Frampton
P2860
P2888
P304
P356
10.1007/S40265-015-0360-7
P577
2015-03-01T00:00:00Z
P5875
P6179
1006439201